Biotinylated Human LILRB2 / CD85d / ILT4 Protein, Fc, Avitag™ (MALS verified) | LI2-H82F5-25ug

(No reviews yet) Write a Review
SKU:
716-LI2-H82F5-25ug
Availability:
IN STOCK
Weight:
1.20 KGS
€544.00
Frequently bought together:

Description

Biotinylated Human LILRB2 / CD85d / ILT4 Protein, Fc, Avitag™ (MALS verified) | LI2-H82F5-25ug| Gentaur Distribution US, UK & Europe

Leukocyte immunoglobulin-like receptor subfamily B member 2 (LILRB2) is also known as CD85 antigen-like family member D (CD85d), Immunoglobulin-like transcript 4 (ILT-4), Monocyte / macrophage immunoglobulin-like receptor 10 (MIR-10), which is a member of the the subfamily B class of LIR receptors. LILRB2 is receptor for class I MHC antigens. LILRB2 recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles. LILRB2 competes with CD8A for binding to class I MHC antigens. LILRB2 / CD85d inhibits FCGR1A-mediated phosphorylation of cellular proteins and mobilization of intracellular calcium ions.

Source: Biotinylated Human LILRB2, Fc, Avitag (LI2-H82F5) is expressed from human 293 cells (HEK293). It contains AA Gln 22 - Val 461 (Accession # AAH36827.1).

Format: Powder.

Tag: C-Fc & C-Avi.

Expression System: HEK293.

Expression Region: Gln 22 - Val 461.

Conjugate: Biotin-labeled.

Molecular Weight: 76.2 kDa.

Characteristics: This protein carries a human IgG1 Fc tag at the C-terminus, followed by an Avi tag (Avitag™). The protein has a calculated MW of 76.2 kDa. The protein migrates as 90-110 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Purity: 95%.

Buffer: Tris with Glycine,  Arginine and NaCl,  pH7.5.

Storage Conditions: -20℃.

Shipping Conditions: RT

View AllClose

Additional Information

Size:
25 ug
View AllClose